genotoxic impurity profiling - review
DESCRIPTION
includes different analytical techniques used for genotoxic impurity profilingTRANSCRIPT
Impurity profiling in pharmaceuticals-
genotoxic impurities, a review
Presented by
Goutami Perala,
JNTUH
1
A seminar on
Guided by Dr.M.Ajitha,CPS, JNTUH
2
Agenda1.Impurity , classifiction1.Impurity , classifiction
5.Methodology5.Methodology
b)Modern approaches b)Modern approaches
6.A review on genotoxic profiling6.A review on genotoxic profiling
2.Genotoxic impurity2.Genotoxic impurity
3.Systematic approach3.Systematic approach
4. Decision tree4. Decision tree
a)Classical approaches a)Classical approaches
7.Case studies 7.Case studies
8.Conclusion8.Conclusion
Impurity ??Presence of any foreign matter or substance
which differs from the drug substance in terms of its structure, pharmacological, and toxicological effects.
Impurity profiling – what and why?
Genotoxic impurityChemical substances capable of causing direct or indirect
damage to DNA or Chromosomes and lead to change in the
expression of “Gene” thereby leading to Mutated Gene. Which may lead to formation of defective protein Create disorder in the metabolic processes Affect the DNA repair Mechanism
e.g. Alkylating agents, diols, epoxides, nitroso groups, lead, arsenic, etc.
Genotoxic profiling?why is it important?
TTC of a genotoxic impurity :ICH guideline - Threshold of
Toxicological Concern (TTC) is 1.5 μg/day intake of a genotoxic impurity.
In terms of relative concentration limits Concentration limit (ppm) = TTC [μg/day]/dose(g/day].
Scope of genotoxicity: Mutagenesis: the formation of
mutationsCarcinogenesis: the formation of
CancersSome forms of Teratogenesis:
Damage to the DNA
Systematic approach to identify an impurity
Decision Tree: Control Strategy for Genotoxic
Decision Tree: Control Strategy for Genotoxic
Confirmed GTI*Enter Decision tree
Tree
Where, GTI is an intermediate, reagent. Observed by product or likely by-product
Is GTIintroduce d in final step?
Is GTIintroducedpenultimate step?
step
Is GTIintroduced > 4 steps from API
Provide chemicalrationale for removal
Test API and impose limit based ontoxicology assessment
Found inpenultimateat a level ofconcern
conce
Test to demonstrate absenceor rejection efficiency (orprovide chemical rationale for
Demonstrate absence and/orremoval efficiency or establishspecification for registration
9
Methodology
Classical approachseparation and determination of impurities
Modern approachUsing on-line hyphenated separation/spectroscopic methods
10
Classical approach HPLC (recently UPLC)TLC Capillary Electrophoresis Electrophoresis-related Chromatographic Techniques Polarography & UV
Methodology….
11
Hyphenated techniques
HPLC-UV StudiesHPLC-MS StudiesGC-MS StudiesTLC-MS StudiesCE-MS StudiesMEKC-MS and CEC-MS StudiesHPLC-NMR Studies
GC MS
LC –APCI-MSLC NMR
A review on genotoxic profiling….Lee determined methyl-, ethyl- and isopropyl-
methanesulphonates in drugs using GC with flame-ionisation detection (FID) (LOQ of 5 ppm in the drug material)
Sluggett developed a GC-MS method utilising selected-ion monitoring (SIM) mode detection for the trace analysis of a genotoxic impurity carbonic acid chloromethyl tetrahydro-pyran-4-yl ester, present in a beta-lactam API with an LOQ of 10 ppm.
Another approach – chemical derivatisationLee et al. derivatised methyl-, ethyl- and
isopropyl-methanesulphonates as well as dimethyl sulphate with sodium thiocyanate to form the corresponding alkyl thiocyanates.
GC-MS determination - with high sensitivity (LOQ<1 ppm).
A new approaches for the chemically unstable analytes – MATRIX DEACTIVATION
17
TLC-MS
TLC-MS Separated spots on the plate could be subjected to direct matrix-assisted-laser-desorption ionization
Time-of-flight mass spectrometry (TLC-MALDI TOF -MS) no need to remove the spots from plate
Only wetting spot with methanol required to transfer the analyte from inside the silica gel to the surface thus enhancing the MALDI-TOF-MS signal
Modern approach
TLC PLATE
MEOH
CASE STUDY 1-The Case of EMS Ethyl methly sulphonate A direct DNA damaging agent(alkylator)As an impurity in Viracept (nelfinavir
mesylate) tablets (mnfd by Roche Ltd) in june 2007 – formulation recalled from european market
maximal dose of 0.055 mg/kg/d
Hydrazine as impurity –case study2Hydrazine was observed as a by-product
reaction in a drug substance indicated for cancer.
Max’ dose of the drug - 500 mg/d,NMT 2yrsAs per USEPA a lifetime exposure of 5876
mcg – cancer risk.The acceptable daily dose for hydrazine was
8 mcg/d (5876 mcg/[365*2]). Dose of drug fixed based on this
Conclusion :Impurity profiling is very important in the field of pharmaceutical
analysisUnidentified and potentially genotoxic impurities are health hazards and
in order to increase safety, these impurities should be identified.Assessment and control of GTIs in chemical process
development is challenging, owing to the evolving nature of the synthetic process, variable points of entry of GTIs in the process, and the need for analytical measurements with adequate selectivity and sensitivity.
Impossible to eliminate all impurities & Often it is impractical to detect all those trace ones.
However it is not possible to assess the exact limit for a genotoxic impurity, just estimation. So precautions ...
References Genotoxic impurities - strategies for
Identification and Control, Edited by Andrew Teasdale
Wikipedia http://www.wiley.com/WileyCDA/WileyTitle/pr
oductCd-0470499192.htmlwww.science direct.comhttp://www.ema.europa.eu/docs/en_GB/docu
ment_library/Scientific_guideline/2009/09/WC500002903.pdf
http://www.ipapharma.org/events/IPA%20-%20EDQM%20pdf/Manjunath%20Bhanu%20-%20Impurities%20Characterization.pdf
22
HYDERABAD
Thank you